Search
 

Valeant Shatters Creditor Calm

What happens when debt markets lose confidence in a company's bonds.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Valeant Pharmaceuticals International Inc. is losing the confidence of its biggest investor base: debt markets that lent the drugmaker more than US$30 billion to fund its rapid expansion.

Recommended Stories

The Loan Arranger Rides Again

John R. Cryan |

What to do about the conflicts of interest prevalent in today’s corporate borrowing.

Wall Street's Big Moneymaker Isn't Sexy

Nisha Gopalan & Andy Mukherjee |

Cash management banking offers 20% return on equity, driving geographic expansion of big banks' transaction banking services offered.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.